The association of bone mineral density and parathyroid hormone with serum magnesium in adult patients with sickle-cell anaemia

Archives of Medical Science

Volumn 8, Issue 2, 2012, Pages 270-276

  Elshal, Mohamed F ^a,b   Bernawi, Amna E ^a   Al Ghamdy, Maryam A ^a   Jalal, Jalaluddin A ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Bone mineral density; Bone turnover; Calcium; Magnesium; Osteoporosis; Parathyroid hormone; Sickle cell anaemia

Indexed keywords

CALCIUM; MAGNESIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BLOOD DONOR; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; SICKLE CELL ANEMIA;

EID: 84861475132     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.28554     Document Type: Article

References (39)

1. Gupta R, Marouf R, Adekile A. Pattern of bone mineral density in sickle cell disease patients with the high-Hb f phenotype. Acta Haematol 2010; 123: 64-70.
2. Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R. Bone mass density in adults with sickle cell disease. Br J Haematol 2007; 136: 666-72. (Pubitemid 46148206)
3. Miller RG, Segal JB, Ashar BH, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 2006; 81: 236-41.
4. Kaul DK, Fabry ME, Nagel RL. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev 1996; 10: 29-44. (Pubitemid 26138779)
5. Laroche M, Ludot I, Brousset P, Mazieres B. Osteoporosis with lymphoid nodules and hematopoietic marrow hyperplasia. Clin Exp Rheumatol 1999; 17: 457-60. (Pubitemid 29358010)
6. Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA. Erythrocyte and plasma magnesium in sickle-cell anaemia. East Afr Med J 1990; 67: 348-54.
7. Assaley J, Baron JM, Cibils LA. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. J Perinat Med 1998; 26: 115-9. (Pubitemid 28224775)
8. Huntsman RG, Hurn BA, Lehmann H. Observations on the effect of magnesium on blood coagulation. J Clin Pathol 1960; 13: 99-101.
9. Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA. Urinary magnesium excretion in steady-state sickle cell anaemia. Acta Haematol 1993; 90: 136-8. (Pubitemid 24041988)
10. De Franceschi L, Brugnara C, Rouyer-Fessard P, Jouault H, Beuzard Y. Formation of dense erythrocytes in sad mice exposed to chronic hypoxia: evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies. Blood 1999; 94: 4307-13.
11. Chou HF, Schwartz R, Krook L, Wasserman RH. Intestinal calcium absorption and bone morphology in magnesium deficient chicks. Cornell Vet 1979; 69: 88-103. (Pubitemid 9088844)
12. Sader MS, Legeros RZ, Soares GA. Human osteoblasts adhesion and proliferation on magnesium-substituted tricalcium phosphate dense tablets. J Mater Sci Mater Med 2009; 20: 521-7.
13. Wallach S. Effects of magnesium on skeletal metabolism. Magnes Trace Elem 1990; 9: 1-14. (Pubitemid 20202068)
14. Kanazawa I, Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. A case of magnesium deficiency associated with insufficient parathyroid hormone action and severe osteoporosis. Endocr J 2007; 54: 935-40. (Pubitemid 351346776)
15. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int 2006; 17: 1022-32. (Pubitemid 43864856)
16. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009; 28: 131-41.
17. Shepherd JA, Meta M, Landau J, et al. Metacarpal index and bone mineral density in healthy African-American women. Osteoporos Int 2005; 16: 1621-6. (Pubitemid 41790867)
18. WHO Study Group on Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis, World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]. Geneva, World Health Organization, 1994.
19. Cuka S, Dvornik S, Drazenovic K, Mihic J. Evaluation of the dade behring dimension rxl clinical chemistry analyzer. Clin Lab 2001; 47: 35-40. (Pubitemid 32118097)
20. Wan B, Augustin R, Chan MK, Leblond J, Verjee Z, Adeli K. Analytical performance and workflow evaluation of the roche e170 modular immunoassay analyzer in a pediatric setting. Clin Biochem 2005; 38: 262-71. (Pubitemid 40222327)
21. Broyles DL, Nielsen RG, Bussett EM, et al. Analytical and clinical performance characteristics of tandem-mp ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem 1998; 44: 2139-47. (Pubitemid 28447062)
22. Schmidt-Gayk H, Spanuth E, Kotting J, et al. Performance evaluation of automated assays for beta-crosslaps, n-midosteocalcin and intact parathyroid hormone (biorose multicenter study). Clin Chem Lab Med 2004; 42: 90-5. (Pubitemid 38401475)
23. Tantawy AAG, El-Bostany EA, Matter RM, El-Ghoroury EA, Ragab S. Predictors of bone disease in Egyptian prepubertal children with -thalassaemia major. Arch Med Sci 2010; 6: 584-91.
24. Buchowski MS, de la Fuente FA, Flakoll PJ, Chen KY, Turner EA. Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia. Am J Physiol Endocrinol Metab 2001; 280: E518-27.
25. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted pth response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006; 17: 1013-21. (Pubitemid 43864855)
26. Reginster JY, Strause L, Deroisy R, Lecart MP, Saltman P, Franchimont P. Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 1989; 8: 106-9. (Pubitemid 19165861)
27. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996; 6: 453-61. (Pubitemid 27007699)
28. Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 2003; 19: 458-66. (Pubitemid 36930029)
29. Fung EB, Kawchak DA, Zemel BS, Rovner AJ, Ohene-Frempong K, Stallings VA. Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia. Pediatr Blood Cancer 2008; 50: 620-3. (Pubitemid 351155836)
30. Parfitt AM. The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part i of iv parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism 1976; 25: 809-44.
31. Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN. Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr 1997; 131: 246-51. (Pubitemid 27495245)
32. Suh SM, Tashjian AH Jr, Matsuo N, Parkinson DK, Fraser D. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. J Clin Invest 1973; 52: 153-60.
33. Abou-Samra AB, Zajac JD, Schiffer-Alberts D, et al. Cyclic adenosine 3′,5′-monophosphate (camp)-dependent and camp-independent regulation of parathyroid hormone receptors on umr 106-01 osteoblastic osteosarcoma cells. Endocrinology 1991; 129: 2547-54.
34. Woodard JC, Webster PD, Carr AA. Primary hypomagnesemia with secondary hypocalcemia, diarrhea and insensitivity to parathyroid hormone. Am J Dig Dis 1972; 17: 612-8.
35. Iwasaki Y, Asai M, Yoshida M, Oiso Y, Hashimoto K. Impaired parathyroid hormone response to hypocalcemic stimuli in a patient with hypomagnesemic hypocalcemia. J Endocrinol Invest 2007; 30: 513-6. (Pubitemid 47496462)
36. Mortensen L, Hyldstrup L, Charles P. Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis. Eur J Endocrinol 1997; 136: 52-60. (Pubitemid 27090680)
37. Weinman EJ, Biswas RS, Peng G, et al. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1. J Clin Invest 2007; 117: 3412-20. (Pubitemid 350103365)
38. Koura HM, Ismail NA, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK. A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci 2011; 7: 493-500.
39. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1997; 100: 1847-52. (Pubitemid 27431344)